Madrigal制药公司 (NASDAQ:MDGL) 董事Rebecca Taub于2025年12月10日出售了18,613股普通股，总价值约1030万美元。这些股票的售价在每股547.7567美元至555.39美元之间。

CONSHOHOCKEN, Pa., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the J.P. Morgan Annual Healthcare Conference on ...

Al Madrigal is half Latino, half white. Al Madrigal gets heat from whites for being too Latino and Latinos for being too white. Al Madrigal is called a “pocho,” a derogatory term for Americanized ...

Madrigal Pharmaceuticals, Inc. has secured a $500 million senior secured credit facility from Blue Owl Capital to advance its pipeline focused on treating metabolic dysfunction-associated ...

Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) is one of the high short interest stocks to buy right now. On November 21, H.C.

BofA analyst Jason Zemansky raised the firm’s price target on Madrigal Pharmaceuticals (MDGL) to $581 from $456 and keeps a Neutral rating on the ...

Madrigal Pharmaceuticals, the biotech company based in West Conshohocken, Pennsylvania, saw its share price rise more than 150% today after announcing a successful completion of its Phase II clinical ...

Madrigal Pharmaceuticals (MDGL) is back on investors radar after Rezdiffra s early launch exceeded expectations, putting the MASH therapy on a path toward blockbuster level sales and reshaping the ...

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...

Medicare Advantage should be one of the best solutions for American health policy woes. It keeps costs in check and allows patients the freedom to choose providers they like. Washington needs to ...

Ames High students will continue the long tradition of the Madrigal dinner for the 37th year. Find out how to get tickets.